Jiechuan Qiu
Jinan, 250021, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
N6-methyladenosine-modified ACSM3 mitigates lipid accumulation and suppresses tumor progression in ccRCC via GATA5/HMGCS2 axis and mTORC1 signaling.
Journal: International journal of biological macromolecules
Published: July 21, 2025
FADS3 fuels CcRCC progression via lipid-droplet/TGF-β receptors axis bridging metabolic reprogramming and epithelial plasticity.
Journal: International journal of surgery (London, England)
Published: May 14, 2025
IGFBP1 orchestrates metabolic reprogramming to drive clear cell renal cell carcinoma progression through NR1H4-mediated lipid homeostasis disruption.
Journal: Cancer cell international
Published: February 03, 2025
Low expression of fatty acid oxidation related gene ACADM indicates poor prognosis of renal clear cell carcinoma and is related to tumor immune infiltration.
Journal: Oncology research
Published: April 07, 2023
High C1QTNF1 expression mediated by potential ncRNAs is associated with poor prognosis and tumor immunity in kidney renal clear cell carcinoma.
Journal: Frontiers in molecular biosciences
Published: April 06, 2023
Sphingosine kinase 1 regulates lipid metabolism to promote progression of kidney renal clear cell carcinoma.
Journal: Pathology, research and practice
Published: March 16, 2023
WITHDRAWN: Comprehensive Analysis of the Role of CXCL Family Members in Clear Cell Renal Cell Carcinoma
Journal: Current cancer drug targets
Published: November 01, 2022
Low expression of SLC34A1 is associated with poor prognosis in clear cell renal cell carcinoma.
Journal: BMC urology
Published: October 31, 2022
Establishment of a new prognostic risk model of MAPK pathway-related molecules in kidney renal clear cell carcinoma based on genomes and transcriptomes analysis.
Journal: Frontiers in oncology
Published: October 22, 2022
Showing 1-10 of 10
Last Updated: 09/26/2026